References
- Schonberger LB, Bregman DJ, Sullivan-Bolyai JZ et al. Guillain–Barrée syndrome following vaccination in the National Influenza Immunization Program, United States, 1976–1977. Am. J. Epidemiol. 110(2), 105–123 (1979).
- Sejvar JJ, Kohl KS, Gidudu J et al.; Brighton Collaboration GBS Working Group. Guillain–Barré syndrome and Fisher syndrome: case definitions and guidelines for collection, analysis, and presentation of immunization safety data. Vaccine 29(3), 599–612 (2011).
- Salmon DA, Proschan M, Forshee R et al. Association between Guillain–Barré syndrome and influenza A (H1N1) 2009 monovalent inactivated vaccines in the USA: a meta-analysis. Lancet 381(9876), 1461–1468 (2013).
- Dieleman J, Romio S, Johansen K et al. Guillain–Barré syndrome and adjuvanted pandemic influenza A (H1N1) 2009 vaccine: multinational case-control study in Europe. BMJ 343, d3908 (2011).
- De Wals P, Deceuninck G, Toth E et al. Risk of Guillain–Barré syndrome following H1N1 influenza vaccination in Quebec. JAMA 308(2), 175–181 (2012).
- Huang WT, Yang HW, Liao TL et al. Safety of pandemic (H1N1) 2009 monovalent vaccines in Taiwan: a self-controlled case series study. PLoS ONE 8(3), e58827 (2013).
- Crawford NW, Cheng A, Andrews N et al. Guillain–Barré syndrome following pandemic (H1N1) 2009 influenza A immunisation in Victoria: a self-controlled case series. Med. J. Aust. 197(10), 574–578 (2012).
- Dodd CN, Romio SA, Black S et al. International collaboration to assess the risk of Guillain Barré Syndrome following Influenza A (H1N1) 2009 monovalent vaccines. Vaccine doi:10.1016/j.vaccine.2013.06.032 (2013) ( Epub ahead of print).
- Greene SK, Rett MD, Vellozzi C et al. Guillain–Barré syndrome, influenza vaccination, and antecedent respiratory and gastrointestinal infections: a case-centered analysis in the vaccine safety datalink, 2009–2011. PLoS ONE (2013) ( In Press).
- Lasky T, Terracciano GJ, Magder L et al. The Guillain–Barré syndrome and the 1992-–1993 and 1993-–1994 influenza vaccines. N. Engl. J. Med. 339(25), 1797–1802 (1998).
- Juurlink DN, Stukel TA, Kwong J et al. Guillain–Barré syndrome after influenza vaccination in adults: a population-based study. Arch. Intern. Med. 166(20), 2217–2221 (2006).
- Yuki N, Hartung HP. Guillain–Barré Syndrome. N. Engl. J. Med. 366, 2294–2304 (2012).
- Kokubun N, Shahrizaila N, Koga M, Hirata K, Yuki N. The demyelination neurophysiological criteria can be misleading in Campylobacter jejuni-related Guillain–Barré syndrome. Clin. Neurophysiol. 124(8), 1671–1679 (2013).
- Nachamkin I, Shadomy SV, Moran AP et al. Anti-ganglioside antibody induction by swine (A/NJ/1976/H1N1) and other influenza vaccines: insights into vaccine-associated Guillain–Barré syndrome. J. Infect. Dis. 198(2), 226–233 (2008).
- Wang DJ, Boltz DA, McElhaney J, McCullers JA, Webby RJ, Webster RG. No evidence of a link between influenza vaccines and Guillain–Barrée syndrome-associated antiganglioside antibodies. Influenza Other Respi. Viruses 6(3), 159–166 (2012).
- Lei T, Siu KL, Kok KH et al. Anti-ganglioside antibodies were not detected in human subjects infected with or vaccinated against 2009 pandemic influenza A (H1N1) virus. Vaccine 30(16), 2605–2610 (2012).
- Sejvar JJ, Pfeifer D, Schonberger LB. Guillain–bBarré syndrome following influenza vaccination: causal or coincidental? Curr. Infect. Dis. Rep. 13(4), 387–398 (2011).
- IOM (Institute of Medicine). Adverse effects of vaccines: Influenza Vaccines and Neurological Complications. The National Academics Press, Washington, DC, USA (2004).
- IOM (Institute of Medicine). Adverse effects of vaccines: evidence and causality. The National Academics Press Washington, DC, USA (2012).
- CDC estimates of deaths associated with seasonal influenza – United States, 1976–2007. MMWR 59(33), 1057–1062 (2010).